About
Protheragen is a comprehensive partner for early-stage drug development projects, specializing in equity investment, intermediary services, and project incubation. Based in New York, the company has swiftly broadened its scope to encompass diverse segments within the healthcare sector, providing tailored solutions that empower innovators and streamline the drug development process. With a commitment to fostering growth and innovation, Protheragen leverages its expertise to connect promising projects with essential resources and strategic guidance, ensuring a robust pathway from concept to market.